Anuh Pharma Limited (NSE:ANUHPHR)
India
· Delayed Price · Currency is INR 210.70
+2.65 (1.27%)
At close: Jun 27, 2025, 3:30 PM IST
Anuh Pharma Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 6,615 | 6,470 | 5,275 | 4,866 | 4,320 | Upgrade
| |
Revenue Growth (YoY) | 2.24% | 22.66% | 8.39% | 12.66% | 40.72% | Upgrade
|
Cost of Revenue | 4,994 | 4,914 | 4,075 | 3,809 | 3,329 | Upgrade
|
Gross Profit | 1,621 | 1,556 | 1,200 | 1,057 | 990.23 | Upgrade
|
Selling, General & Admin | 230.39 | 206.91 | 180.15 | 156.67 | 147.57 | Upgrade
|
Other Operating Expenses | 781.98 | 596.15 | 486.85 | 417.13 | 394.33 | Upgrade
|
Operating Expenses | 1,100 | 887.24 | 762.31 | 691.69 | 694.83 | Upgrade
|
Operating Income | 521.69 | 668.73 | 437.21 | 365.35 | 295.4 | Upgrade
|
Interest Expense | -6.19 | -3.54 | -2.18 | -9.61 | -14.95 | Upgrade
|
Interest & Investment Income | - | 12.68 | 14.98 | 23.98 | 21.08 | Upgrade
|
Currency Exchange Gain (Loss) | - | -2.86 | -21.46 | -16.49 | 3.02 | Upgrade
|
Other Non Operating Income (Expenses) | 94.55 | 1.08 | 2.63 | 1.01 | 0.85 | Upgrade
|
EBT Excluding Unusual Items | 610.05 | 676.1 | 431.17 | 364.24 | 305.4 | Upgrade
|
Gain (Loss) on Sale of Investments | - | 107.21 | 43.39 | 26.37 | 80.44 | Upgrade
|
Gain (Loss) on Sale of Assets | - | -0.22 | 0.15 | 0.62 | -0.32 | Upgrade
|
Pretax Income | 610.05 | 783.1 | 474.7 | 391.22 | 385.51 | Upgrade
|
Income Tax Expense | 136.53 | 182.52 | 112.91 | 85.61 | 101.15 | Upgrade
|
Net Income | 473.52 | 600.58 | 361.8 | 305.61 | 284.36 | Upgrade
|
Net Income to Common | 473.52 | 600.58 | 361.8 | 305.61 | 284.36 | Upgrade
|
Net Income Growth | -21.16% | 66.00% | 18.38% | 7.47% | 98.78% | Upgrade
|
Shares Outstanding (Basic) | 50 | 50 | 50 | 50 | 50 | Upgrade
|
Shares Outstanding (Diluted) | 50 | 50 | 50 | 50 | 50 | Upgrade
|
Shares Change (YoY) | -0.01% | - | - | - | - | Upgrade
|
EPS (Basic) | 9.45 | 11.98 | 7.22 | 6.10 | 5.67 | Upgrade
|
EPS (Diluted) | 9.45 | 11.98 | 7.22 | 6.10 | 5.67 | Upgrade
|
EPS Growth | -21.15% | 66.00% | 18.38% | 7.47% | 98.78% | Upgrade
|
Free Cash Flow | 169.79 | 79.09 | 523.52 | 272.49 | -248.89 | Upgrade
|
Free Cash Flow Per Share | 3.39 | 1.58 | 10.45 | 5.44 | -4.97 | Upgrade
|
Dividend Per Share | 1.500 | 2.500 | 2.000 | 1.750 | 1.500 | Upgrade
|
Dividend Growth | -40.00% | 25.00% | 14.29% | 16.67% | 9.09% | Upgrade
|
Gross Margin | 24.51% | 24.05% | 22.74% | 21.72% | 22.92% | Upgrade
|
Operating Margin | 7.89% | 10.34% | 8.29% | 7.51% | 6.84% | Upgrade
|
Profit Margin | 7.16% | 9.28% | 6.86% | 6.28% | 6.58% | Upgrade
|
Free Cash Flow Margin | 2.57% | 1.22% | 9.93% | 5.60% | -5.76% | Upgrade
|
EBITDA | 609.09 | 751.06 | 531.16 | 481.55 | 440.63 | Upgrade
|
EBITDA Margin | 9.21% | 11.61% | 10.07% | 9.89% | 10.20% | Upgrade
|
D&A For EBITDA | 87.39 | 82.33 | 93.95 | 116.2 | 145.23 | Upgrade
|
EBIT | 521.69 | 668.73 | 437.21 | 365.35 | 295.4 | Upgrade
|
EBIT Margin | 7.89% | 10.34% | 8.29% | 7.51% | 6.84% | Upgrade
|
Effective Tax Rate | 22.38% | 23.31% | 23.79% | 21.88% | 26.24% | Upgrade
|
Revenue as Reported | 6,710 | 6,591 | 5,336 | 4,918 | 4,425 | Upgrade
|
Advertising Expenses | - | 7.37 | 3.17 | 0.18 | 0.18 | Upgrade
|
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.